X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-05 | IMGN | Coen Stacy Ann | SVP, Chief Business Officer | S - Sale+OE | $29.30 | -4,583 | 73,274 | -6% | -$134,282 | |||||
| D | 2024-02-05 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $29.30 | -12,027 | 21,039 | -36% | -$352,391 | |||||
| D | 2024-02-05 | IMGN | Enyedy Mark J | CEO | S - Sale+OE | $29.28 | -20,107 | 584,397 | -3% | -$588,733 | |||||
| D | 2024-02-05 | IMGN | Lentini Renee | VP, PRIN ACCTG OFFICER | S - Sale+OE | $29.30 | -2,631 | 14,723 | -15% | -$77,088 | |||||
| D | 2024-01-16 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $29.64 | -187,667 | 3,426 | -98% | -$5,562,450 | |||||
| D | 2023-12-26 | IMGN | Lentini Renee | VP, PRIN ACCTG OFFICER | S - Sale+OE | $29.74 | -6,548 | 8,452 | -44% | -$194,738 | |||||
| D | 2023-12-15 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $29.40 | -117,445 | 2,811 | -98% | -$3,452,883 | |||||
2023-11-30 | IMGN | Coen Stacy Ann | SVP, Chief Business Officer | S - Sale | $29.20 | -3,826 | 33,140 | -10% | -$111,719 | ||||||
| D | 2023-11-30 | IMGN | Peterson Kristine | Dir | S - Sale+OE | $28.90 | -20,000 | 0 | -100% | -$578,000 | |||||
| DM | 2023-11-29 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $28.46 | -171,216 | 2,811 | -98% | -$4,873,230 | |||||
| D | 2023-11-15 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $15.85 | -166,725 | 2,811 | -98% | -$2,642,591 | |||||
| DM | 2023-11-15 | IMGN | Coen Stacy Ann | SVP, Chief Business Officer | S - Sale+OE | $16.04 | -108,609 | 36,966 | -75% | -$1,741,959 | |||||
| D | 2023-11-07 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $16.66 | -19,517 | 2,811 | -87% | -$325,153 | |||||
| D | 2023-11-06 | IMGN | Lentini Renee | VP, PRIN ACCTG OFFICER | S - Sale+OE | $15.29 | -219,545 | 0 | -100% | -$3,356,843 | |||||
| D | 2023-10-16 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $14.40 | -192,004 | 2,811 | -99% | -$2,764,858 | |||||
| D | 2023-09-15 | IMGN | Wingrove Theresa | SVP of Regulatory Affairs | S - Sale+OE | $15.44 | -192,013 | 2,811 | -99% | -$2,964,681 | |||||
| D | 2023-08-09 | IMGN | Coen Stacy Ann | SVP, Chief Business Officer | S - Sale+OE | $14.20 | -100,210 | 10,960 | -90% | -$1,422,982 | |||||
| DM | 2023-08-02 | IMGN | Coen Stacy Ann | SVP, Chief Business Officer | S - Sale+OE | $17.10 | -84,581 | 10,960 | -89% | -$1,446,659 | |||||
| DM | 2023-08-02 | IMGN | Enyedy Mark J | CEO | S - Sale+OE | $17.01 | -3,007,554 | 553,270 | -84% | -$51,144,788 | |||||
| D | 2023-08-02 | IMGN | Lentini Renee | PRIN. FIN , ACCTG. Officer | S - Sale+OE | $17.55 | -148,277 | 73,876 | -67% | -$2,602,261 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |